The serum galactomannan index predicts mortality in hematopoietic stem cell transplant recipients with invasive aspergillosis.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 23759343.
- Also identified by DOI 10.1093/cid/cit393 and PMC identifier 3765008.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We examined the relationship between serum and bronchoalveolar lavage (BAL) galactomannan index (GMI) values and mortality in allogeneic hematopoietic cell transplant recipients with invasive pulmonary aspergillosis. Using a clinical sign and symptom-initiated approach, we found that the serum but not the BAL GMI level correlated with 42- and 180-day patient mortality.
Medical subject headings
- Hematopoietic Stem Cell Transplantation
- Invasive Pulmonary Aspergillosis
- Mannans